Expression of cyclooxygenase 2 and cytosolic phospholispase A 2 in the liver tissue of patients with chronic hepatitis and liver cirrhosis

Hepatology Research

Volumn 23, Issue 3, 2003, Pages 185-195

  Cheng, Jidong ^a,b   Imanishi, Hiroyasu ^a   Iijima, Hiroko ^a   Shimomura, Soji ^a   Yamamoto, Tetsuya ^a   Amuro, Yoshiki ^a   Kubota, Akira ^a   Hada, Toshikazu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cyclooxygenase 2; Cytosolic phospholipase A 2; Hepatic fibrogenesis; Hyaluronan

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; FORMALDEHYDE; HYALURONIC ACID; ISOENZYME; PARAFFIN; PHOSPHOLIPASE A2; PROSTACYCLIN; PROSTAGLANDIN H2; THROMBOXANE;

ADULT; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOPLASM; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FIBROGENESIS; HEPATITIS VIRUS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVIEW; STAGING; WESTERN BLOTTING;

EID: 0037411105     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00177-2     Document Type: Article

References (31)

1. Ristimaki A, Gurfinkel S, Wessendorf J, Maciag T, Hla T. Induction of cyclooxygenase-2 by interleukin-1 α; evidence for post-transcriptional regulation. J Biol Chem 1994;269:11769-75.
2. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8.
3. Crofford LJ, Wilder RL, Ristimaki AP, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissue; effects of interleukin-1β, phorbol ester and corticosteroids. J Clin Invest 1994;93:1095-101.
4. Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, Dubois RN. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10 (- / -) mice. Gastroenterology 2000;118:337-45.
5. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-9.
6. Molina Ma, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope F. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 1999;59:4356-62.
7. Ochiai M, Oguri T, Isobe T, Ishioka S, Yamakido M. Cyclooxygenase-2 mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn J Cancer Res 1999;90:1338-43.
8. Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor differentiation. Hepatology 1999;29:688-96.
9. Kondo M, Yamamoto H, Nagano H, et al. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease free survival in patients with hepatocellular carcinoma. Clin Cancer Res 1999;5:4005-12.
10. Tsujii M, Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
11. Pilbeam CC, Kawaguchi H, Hakeda Y, Voznesensky O, Alander CB, Raisz LG. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem 1993;268:25643-9.
12. 2 generation in rat 3Y1 fibroblasts. J Biol Chem 1998;273:1733-40.
13. 2 and cyclooxygenase 2 in human squamous carcinoma A431 cells. Prostaglandins 1997;53:355-69.
14. 2 activity in rats with cirrhosis and ascites. Hepatology 1998;27:42-7.
15. Ichida F, Tsuji T, Omata M, et al. New Inuyama Classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commum 1996;6:112-9.
16. Dewitt DL. Prostagladin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1991;1083:121-34.
17. Kurumbail R.G., Stevens A.M., Gierse J.K. et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents, Nature 384: 644-648.
18. Murtinsanz P, Callejas NA, Casado M, Diaz-Guerra MJM, Bosca L. Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. Br J Phamacol 1998;125:1313-9.
19. Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 1999;96:2345-9.
20. Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 interleukin-1β, tumor necrosis factor-α, and transforming growth factor-β1 in human lung fibroblasts. Exp Cell Res 1998;241:222-9.
21. Cuo J, Lang JA, Miller MW. Transforming growth factor β1 regulates the expression of cyclooxygenase in cultured cortical astrocytes and neurons. J Neurochem 1998;71:526-34.
22. Sheng H, Shao J, Dixon DA, et al. Transforming growth factor-β1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cell via stabilization of mRNA. J Biol Chem 2000;275:6628-35.
23. Geuchot J, Serfaty L, Bonnand AM, Chazuilleres O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000;32:447-52.
24. Ruwart MJ, Rush BD, Synder KF, Peters KM, Appleman HD, Henley KS. 16, 16-dimethyl prostaglandin E2 delays collagene formation in nutritional injury in rat liver. Hepatology 1988;8:61-4.
25. 1 analog reduces rat heptic and Ito cell collagen gene expression and collagen accmulation after bile duct ligation injury. Hepatology 1993;17:707-13.
26. 1 increases liver fibrosis and collateral blood flow in bile-duct-ligated rats. J Hepatol 1999;30:70-6.
27. 2 . FEBS Lett 1995;357:33-6.
28. 1 alpha in the course of liver cirrhosis. Prostaglandins 1997;53:11-20.
29. 2 . J Biol Chem 1997;272:16 709-6 712.
30. 2 . J Biol Chem 1997;272:16069-6072.
31. 2 activity in rats. J Clin Invest 1996;98:365-71.